Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01179
|
|||||
| Drug Name |
Pranlukast
|
|||||
| Synonyms |
Azlaire; Azlaire (TN); N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide; Pranlukast (INN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antiasthmatic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C27H23N5O4
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
|
|||||
| InChI |
InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)
|
|||||
| InChIKey |
NBQKINXMPLXUET-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 103177-37-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 481.5 | Topological Polar Surface Area | 119 | ||
| Heavy Atom Count | 36 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
4.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103188207
, 103933734
, 104307712
, 125335358
, 126620941
, 126652683
, 126670729
, 128679004
, 135072791
, 135692295
, 135698209
, 137212400
, 139795808
, 144206505
, 14859100
, 152106761
, 162182220
, 163032211
, 164232709
, 164826461
, 175611959
, 176484201
, 177749374
, 178100541
, 179149492
, 186010627
, 196105989
, 198972268
, 210279434
, 210281757
, 223653303
, 223704738
, 225068984
, 226395820
, 250136802
, 251887611
, 252156957
, 29223965
, 4500848
, 50077761
, 50077772
, 50126316
, 53786954
, 77504954
, 85220005
, 91615698
, 92308832
, 92719276
, 96025094
, 96078242
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.